CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-11-26

Reporting Person: Del Carmen Jeffrey (Chief Commercial Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-26	Common Stock, par value $0.001 per share	M	10983	$4.21	Acquired	14945	Direct
2025-11-26	Common Stock, par value $0.001 per share	S	10983	$23.331	Disposed	3962	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-26	Options to purchase common stock	$4.21	M	10983	Acquired	2027-01-06	Common Stock (10983)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Shares were sold in various lots from $23.331 to $23.345 per share. The price listed represents a weighted average price for the shares sold.

F3: Options previously vested in three annual tranches beginning on January 6, 2021.